Tier 2 Dermatology Service for NHS MSE ICB

Contract summary

Industry

• Health services - 85100000

Location of contract

East of England

Value of contract

£1,027,687

Procurement reference

tender_348230/1282230

Published date

14 November 2023

Closing date

31 March 2023

Closing time

12pm

Contract start date

1 April 2023

Contract end date

31 March 2024

Contract type

Service contract

Procedure type

Single tender action (below threshold)

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

---

Description

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032162) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 ("PCR 2015") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020).

In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.)

The Authority intends to enter into a contract for 6 months, with the option to extend for a further 6 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £1,027,687.

---

More information

Additional text

This a contract award notice, published in Contracts Finder, which reflects the Voluntary ex-ante transparency notice (Notice Number: 2023/S 000-032162) (VEAT notice) published on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 ("PCR 2015") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020).

In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.)

The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the "Regulations"). As such, the Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services.

This is a non-recurrent contract to ensure continuity of care, safe and effective access to care and dermatology services for the patients of Mid and South Essex during this transitional, interim period. The Authority will publish appropriate Notices accordingly to communicate any such future changes to the market, once final.

---

Award information

Awarded date

16 October 2023

Contract start date

1 April 2023

Contract end date

31 March 2024

Total value of contract

£1,027,687

This contract was awarded to 1 supplier.

Mid and South Essex NHS Foundation Trust (MSEFT)

---

About the buyer

Contact name

NHS Mid and South Essex Integrated Care Board

Address

Phoenix House, Christopher Martin Rd,
Basildon
SS14 3HG
England

Email

cariad.burgess@attain.co.uk

Website

https://www.midandsouthessex.ics.nhs.uk/